Boston Scientific Corporation
US ˙ NYSE ˙ US1011371077

SecurityBSX / Boston Scientific Corporation
InstitutionSummit Trail Advisors, Llc
Latest Disclosed Ownership30,942 shares
Latest Disclosed Value $ 1,941,610
Summit Trail Advisors, Llc reports 12.41% increase in ownership of BSX / Boston Scientific Corporation

On May 12, 2026 - Summit Trail Advisors, Llc filed a 13F-HR form disclosing ownership of 30,942 shares of Boston Scientific Corporation (US:BSX) valued at $1,941,610 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 27,526 shares of Boston Scientific Corporation. This represents a change in shares of 12.41% during the quarter. The current value of the position is $1,475,624 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F BOSTON SCIENTIFIC COM 101137107 30,942 3,416 12.41 1,942 -26.03 0.0278
2026-02-17 2025-12-31 13F BOSTON SCIENTIFIC COM 101137107 27,526 -6,880 -20.00 2,625 -21.88 0.0454
2025-11-14 2025-09-30 13F BOSTON SCIENTIFIC COM 101137107 34,406 -317 -0.91 3,359 -9.92 0.0464
2025-08-14 2025-06-30 13F BOSTON SCIENTIFIC COM 101137107 34,723 34,723 3,730 0.0640
2025-01-29 2024-12-31 13F BOSTON SCIENTIFIC COM 101137107 0 -12,342 -100.00 0 -100.00
2024-11-12 2024-09-30 13F BOSTON SCIENTIFIC COM 101137107 12,342 1,575 14.63 1,034 24.73 0.0256
2024-08-13 2024-06-30 13F Boston Scientific COM 101137107 10,767 1,403 14.98 829 29.33 0.0218
2024-04-23 2024-03-31 13F BOSTON SCIENTIFIC COM 101137107 9,364 884 10.42 641 30.82 0.0170
2024-02-06 2023-12-31 13F BOSTON SCIENTIFIC COM 101137107 8,480 -1,265 -12.98 490 -4.67 0.0162
2023-10-30 2023-09-30 13F BOSTON SCIENTIFIC COM 101137107 9,745 1,714 21.34 515 18.43 0.0189
2023-07-25 2023-06-30 13F BOSTON SCIENTIFIC COM 101137107 8,031 2,816 54.00 434 66.92 0.0164
2023-05-04 2023-03-31 13F BOSTON SCIENTIFIC COM 101137107 5,215 5,215 261 0.0105
2018-08-10 2018-06-30 13F BOSTON SCIENTIFIC CORP COM EQUITY 101137107 0 -194,923 -100.00 0 -100.00
2018-05-21 2018-03-31 13F BOSTON SCIENTIFIC CORP COM EQUITY 101137107 194,923 189,993 3,853.81 195 44.44 0.0304
2018-02-14 2017-12-31 13F BOSTON SCIENTIFIC EQUITY 101137107 4,930 4,930 135 0.0170
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.